Alpha Teknova, Inc.
General ticker "TKNO" information:
- Sector: Health Care
- Industry: Life Sciences Tools & Services
- Capitalization: $301.9M (TTM average)
Alpha Teknova, Inc. follows the US Stock Market performance with the rate: 3.6%.
Estimated limits based on current volatility of 2.8%: low 4.58$, high 4.84$
Factors to consider:
- Total employees count: 173 (-18.0%) as of 2024
- US accounted for 95.2% of revenue in the fiscal year ended 2024-12-31
- Top business risk factors: Operating losses, Demand from major customers, Product quality issues, Catastrophic events, Regulatory and compliance
- Price in estimated range
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [4.28$, 11.39$]
- 2025-12-31 to 2026-12-31 estimated range: [2.80$, 7.69$]
Financial Metrics affecting the TKNO estimates:
- Negative: with PPE of -14.0 at the end of fiscal year the price was high
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -3.22 <= 0.33
- Negative: negative Industry operating cash flow (median)
- Negative: negative Net income
- Positive: Inventory ratio change, % of -8.78 <= -0.75
- Positive: Industry inventory ratio change (median), % of -1.41 <= -0.15
- Positive: -14.38 < Investing cash flow per share per price, % of -7.08
Short-term TKNO quotes
Long-term TKNO plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $41.42MM | $36.68MM | $37.74MM |
| Operating Expenses | $91.08MM | $72.25MM | $63.89MM |
| Operating Income | $-49.66MM | $-35.56MM | $-26.15MM |
| Non-Operating Income | $0.27MM | $-1.51MM | $-0.69MM |
| Interest Expense | $0.00MM | $0.83MM | $0.69MM |
| R&D Expense | $7.74MM | $5.57MM | $2.76MM |
| Income(Loss) | $-49.39MM | $-37.08MM | $-26.83MM |
| Taxes | $-1.92MM | $-0.30MM | $-0.09MM |
| Profit(Loss)* | $-47.47MM | $-36.78MM | $-26.75MM |
| Stockholders Equity | $99.89MM | $90.04MM | $82.39MM |
| Inventory | $12.25MM | $11.59MM | $6.80MM |
| Assets | $152.26MM | $128.59MM | $118.77MM |
| Operating Cash Flow | $-27.40MM | $-18.81MM | $-12.39MM |
| Capital expenditure | $28.15MM | $7.93MM | $1.12MM |
| Investing Cash Flow | $-28.15MM | $-7.74MM | $-27.27MM |
| Financing Cash Flow | $10.27MM | $12.80MM | $14.89MM |
| Earnings Per Share** | $-1.69 | $-1.16 | $-0.57 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.